baber/WOPTO huggingface dataset:
Patent NZ-528554-A (NZ)
Title: Pharmaceutical compositions comprising substance that modulate AILIM for treating inflammatory bowel diseases
Inventor: WATANABE MAMORU
IPC: A61P1/04
Filed: 2002-02-18
Abstract: Use of an antibody, polypeptide or fusion polypeptide active to modulate signal transduction via the activation inducible lymphocyte immunomodulatory molecule (AILIM or AILM) in the manufacture of a medicament for the treatment of colitis or alimentary allergy. Use of an antisense DNA or RNA that inhibits transcription or translation of AILIM (AILM) in the manufacture of a medicament for the treatment of colitis or alimentary allergy.
Patent NZ-531172-A (NZ)
Title: Heterocyclic amine-type compounds for treating fibromyalgia and chronic fatigue syndrome
Inventor: MCCALL ROBERT B
IPC: A61P21/00
Filed: 2001-04-17
Abstract: Use of a heterocyclic amine-type compound of formula (A) to prepare a medicament for the treatment of symptoms of fibromyalgia syndrome, or chronic fatigue syndrome is disclosed, wherein the variables are as defined in the specification. (62) Divided out of 522112
Patent NZ-532182-A (NZ)
Title: Hollow interconnecting panels as lost formwork
Inventor: DINCEL BURAK
IPC: E04C2/20
Filed: 2002-10-10
Abstract: An elongated building element (14) to form a series of walls (10) to (13). The elements (14) each have longitudinally extending flanges (21) that snap engage with longitudinally extending grooves (19) in the next adjacent element (14). Accordingly the wall (10) is constructed by joining the elements (14) in a direction transverse their general direction of extension. If so required the elements (14) may be filled with concrete.
Patent NZ-536489-A (NZ)
Title: Use of plant extracts as a terrestrial molluscicidal and/or mollosc-repellant agent
Inventor: BOWEN IVOR DELME
IPC: A01N65/00
Filed: 2003-05-02
Abstract: Disclosed is the use of plant material derived from a plant in the family Caesalpiniaceae, Olaceae, Polygonaceae or Bursecaceae as a terrestrial molluscicidal and/or mollusc-repellant agent. Also described are molluscicidal and/or mollusc-repellant preparations comprising plant material having molluscicidal and/or mollusc-repellant activity and a particulate, wherein the plant material is obtained from Caesalpiniaceae, Olaceae, Polygonaceae or Bursecaceae, preferably Commiphora molmol or Commiphora guidotti.
Patent NZ-539120-A (NZ)
Title: Device for selectively regulating the flow rate of a fluid
Inventor: MABRY ERIC
IPC: A61M5/14
Filed: 2003-09-18
Abstract: Disclosed herein is a device for selectively regulating the flow rate of a fluid, comprising: a housing including an inlet and an outlet; a plurality of flow conduits fluidly connected between the inlet and the outlet, the flow conduits being of substantially equal inside diameters, each of the flow conduits having a length representative of a different pre-defined flow rate, wherein each of the flow conduits includes a resiliently compressible occlusion tube; and a flow rate selection mechanism, operatively mounted in the housing, for selectively obstructing fluid flow through the flow conduits, thereby to provide a flow rate from the inlet to the outlet corresponding to the combined flow rates of the unobstructed flow conduits, wherein the flow rate selection mechanism comprises: a flow-blocking element operatively associated with each of the occlusion tubes, each flow-blocking element being selectively operable to block fluid flow through its associated occlusion tube, wherein each of the flow-blocking elements comprises a resilient element that is movable into and out of a flow-blocking compression against its associated occlusion tube; and an actuation mechanism operatively engageable with each of the flow- blocking elements and movable among a plurality of pre-defined positions in all but one of which it operatively engages one or more of the flow-blocking elements to block flow through the occlusion tube associated with each of the operatively engaged flow-blocking elements, and in one position of which it operatively engages none of the flow-blocking elements, wherein the actuation mechanism comprises a plurality of cam elements, each of which is positioned operatively to move one of the resilient elements into a flow-blocking compression against its associated occlusion tube.
Patent NZ-540085-A (NZ)
Title: Novel hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for preparing them
Inventor: HOFGEN NORBERT
Filed: 2003-11-14
Abstract: Disclosed are compounds and processes for comparing compounds of general formula 1 wherein: n is 1 or 2; and R1 is optionally substituted alkyl; R2 and R3 are H or optionally substituted alkyl or NR2R3 together forms a saturated or unsaturated five membered or six membered ring which can contain up to 3 heteroatoms, wherein at least one of R2 and R3 is other than H; and R4 and R5 are H or OH wherein at least one of R4 and R5 is OH. Compounds of the type disclosed are phosphodiesterase-4 inhibitors useful in the treatment of diseases associated with the activity of eosinophils and neutrophils.
Patent NZ-544134-A (NZ)
Title: Insulated shipping containers
Inventor: DERIFIELD RODNEY M
IPC: F25D3/08
Filed: 2004-07-07
Abstract: Disclosed are shipping containers, and more particularly insulated shipping containers, for holding temperature sensitive products and coolant in a predetermined relationship to maintain a refrigerated or frozen condition for an extended period of time. Containers of this type can be moulded from rigid polyurethane foam or other materials for shipping or transporting products such as biological and similar products which need to be maintained at 2 DEG to 8 DEG Centigrade or frozen. Specific constructions are shown and described.
Patent NZ-544758-A (NZ)
Title: Drink dispenser with dispensing line that can be hinged open
Inventor: PAKKERT ENGBERT HERMANNES
IPC: B67D1/00
Filed: 2004-07-15
Abstract: Disclosed is a drink dispenser, which is provided with a chamber with an opening for accommodating a container containing carbonated drink. The container is provided with an outlet closed by a first shut-off valve. A dispensing head, that during use is connected via a line to the outlet, has an operating member for opening and closing the line, wherein the line has a relatively stiff line section with a first part and a second part that are in contact with one another in a contact plane extending in a longitudinal direction of the line, and which can be taken apart to provide access to an internal surface of the relatively stiff line section. A sealing means, extending in the longitudinal direction of the relatively stiff line section, is arranged in or close to the contact plane to form a liquid barrier, wherein the first and second line parts have a clamping member that is able to engage on a locking element for fixing the first and second line parts in a position in contact with one another.
Patent NZ-545621-A (NZ)
Title: Plant genes and polypeptides capable of altering the growth and/or shape of lateral shoot organs in a plant or alter the lateral shoot organs in a plant cell
Inventor: WHITE DEREK
Filed: 2006-03-13
Abstract: Disclosed is the use of an isolated nucleic acid molecule having a nucleotide sequence comprising a sequence selected from SEQ ID NOs. 1, 2, 4, 5 or 7 to alter the growth and/or shape of lateral shoot organs in a plant or alter the lateral shoot organ genes in a plant cell.
Patent NZ-546044-A (NZ)
Title: Pyrimidothiophene compounds
Inventor: DYMOCK BRIAN WILLIAM
IPC: A61P29/00
Filed: 2004-08-26
Abstract: Disclosed are pyrimidothiophene compounds of formula (I) wherein the substituents are as described in the specification. The compounds disclosed are HSP90 inhibitors useful in the treatment of diseases such as cancer, viral disease, inflammatory disease, cystic fibrosis, hypoxia-ischemic injury, CJD, HuntingdonÆs disease or AlzheimerÆs disease.
Patent NZ-546966-A (NZ)
Title: Humidity and moisture monitoring and control system
Inventor: FULLER ANDREW C
IPC: F24F3/14
Filed: 2004-10-22
Abstract: This discloses a dehumidification system 10 comprising of a dehumidifier 12, a user interface 16, a humidity sensor for determining relative humidity of an area, means carried by user interface 16 for selecting a desired humidity for area, a building material moisture sensor for measuring the building material moisture in area, a means for selecting a desired building material moisture and a controller interconnected with dehumidifier, humidity sensor, desired humidity selecting means, building material moisture sensor, and desired building material moisture selecting means. The controller activates the dehumidifier 12 when the relative humidity is higher than the desired value, and/or when the actual building material moisture is higher than the desired building material moisture
Patent NZ-549235-A (NZ)
Title: Adenosine receptor agonists
Inventor: PRITCHARD MARTYN CLIVE
IPC: A61P29/00
Filed: 2005-03-04
Abstract: Disclosed are compounds of formula (I), wherein X is OH and R1 is selected from the group consisting of OCH2CHF2, OCH2cyclopropyl, O-(4-cyano)Ph, O-(3-Ph)Ph, O-(2,5-F2)Ph, O-(2,4-F2)Ph, O-(3,4-F2)Ph, O-(2,3,5-F3)Ph, O-(3-Me,4-F)Ph, O-(2-Me)Ph, O-(3-Br)Ph, O-(4-Me)Ph, 5-indanyloxy, O-(3-CH(CH3)2)Ph, OCH2cyclopentyl and O-(2,2,3,3-tetrafluoro-cyclobutyl), or wherein X is H; and R1 is O(CH2)5CH3, or a pharmaceutically acceptable salt thereof. The compounds are useful for the treatment of pain or inflammation.
Patent NZ-549929-A (NZ)
Title: Antimicrobial cut-resistant composite yarn and garments knitted or woven therefrom
Inventor: ANDREWS DEAN RILEY
IPC: D02G3/44
Filed: 2005-04-01
Abstract: An antimicrobial, cut-resistant composite yarn comprising a core including at least one cut-resistant strand, and a cover including at least one strand wrapped around and enclosing the core is disclosed, wherein at least one strand in either the core or the cover is treated with and incorporates an antimicrobial compound and further the yarn includes one or more channel fibers either in the core or the cover to facilitate movement of moisture within the composite yarn so that the moisture contacts the antimicrobial compound, thereby enhancing the efficacy of the antimicrobial compound. The yarn can be used to fabricate cut-resistant garments, such as gloves, worn by meat cutters and others who work with knives, saws and other sharp implements. The antimicrobial effect reduces bacteria, mold and fungi growth on the garments between washings.
Patent NZ-554456-A (NZ)
Title: Lockable strap clamp
Inventor: NEGISHI TOHRU
IPC: A44B99/00
Filed: 2007-04-12
Abstract: A strap loop holder lock includes a body 22 with a cavity into which a clamping member 48 can be removably inserted to clamp a strap 46 between the bottom surface of the clamping member and the bottom of the cavity. A magnet 56 on the bolt 52 sliding within a bore 50 of the clamping member is attracted to another magnet 28 fixed at the bottom of a recess 26 in the side of the body, so that the bolt moves into the recess to lock the clamping member into the cavity of the body. A key 66 can be used to push the bolt back against the magnetic coupling to allow the clamping member to be unlocked and removed from the cavity of the body.
Patent NZ-555337-A (NZ)
Title: Adhesive patch of methyl imidazole carboxylate for the treatment of neurodegenerative disorders
Inventor: DELACK ELAINE A
Filed: 2007-05-23
Abstract: Disclosed is a use of methyl 4-imidazolecarboxylate for preparation of a medicament for treating multiple sclerosis. Said medicament is preferably formulated for administration to a patient in a therapeutically effective amount by transdermal application. Dosage ranges may be from about 0.01 mcg to about 3.0 mcg, with dosages in the range from about 0.1 mcg to about 0.2 mcg being generally preferred when using transdermal administration. Also disclosed is a composition for treatment of multiple sclerosis, comprising: methyl 4-imidazolecarboxylate; and at least one carrier material for introducing said methyl 4-imidazolecarboxylate into the body of a patient suffering from multiple sclerosis. The disclosure also relates to an apparatus for treatment of multiple sclerosis comprising: an adhesive patch for being adhered to the skin of a patient suffering from multiple sclerosis; and at least one transdermal carrier material (such as pluronic lecithin organigel, lipoderm transdermal gels, anhydrous transdermal gels, and combinations thereof) for introducing said methyl 4-imidazolecarboxylate from said patch into the body of said patient.
Patent NZ-561925-A (NZ)
Title: A host cell comprising a vector for production of proteins requiring gamma-carboxylation
Inventor: LOVGREN ANN
IPC: C12N9/04
Filed: 2006-04-10
Abstract: Provided is a host cell, excluding a cell within a human, comprising an expression vector comprising a nucleic acid molecule encoding a protein requiring gamma-carboxylation and associated expression control sequences, and an expression vector comprising a nucleic acid molecule encoding a vitamin K epoxidoreductase and associated expression control sequences, wherein the host cell further comprises a nucleic acid molecule encoding a y-glutamyl carboxylase and associated expression control sequences. Further provided is a method of producing gamma-carboxylated proteins by said cells.
Patent NZ-562957-A (NZ)
Title: Degradable implantable medical devices with material to control degradation rate
Inventor: CRYER BRETT
IPC: A61L27/54
Filed: 2006-04-04
Abstract: Devices and methods are provided for an implantable medical device which is degradable over a clinically relevant period of time. The medical devices may have the form of implants, graft implants, vascular implants, non vascular implants, wound closure implants, sutures, drug delivery implants, biologic delivery implants, urinary tract implants, inter-uterine implants, organ implants, bone implants including bone plates, bone screws, dental implants, spinal disks, or the like. In preferred embodiments, the implantable medical device comprises an implantable luminal prosthesis, such as vascular and non-vascular stents and stents grafts. More particularly the rate of degradation is controlled by features on the surface of the implantable device, the device typically being a stent.
Patent NZ-567558-A (NZ)
Title: Grass endophyte enhanced attributes
Inventor: ROLSTON MAURICE PHILIP
IPC: A01H15/00
Filed: 2005-08-16
Abstract: Disclosed is a method of maintaining endophyte viability in grass seed or of avoiding significant loss of endophyte viability in grass seed due to exposure of said grass seed to elevated temperature, elevated humidity or both, or during transportation of grass seed, comprising: (a) inoculating the grass with AR584 endophyte (AGAL deposit no. NM98/04676 dated 12 May 1998); (b) collecting seeds from the inoculated grass, and (c) exposing the seed to elevated heat or elevated humidity or both, or transporting said grass seed. (62) Divided Out of 541606
Patent NZ-568438-A (NZ)
Title: Plant growth stimulating composition comprising a compound of the caffeine family
Inventor: MARKS DAVID
IPC: A01N43/90
Filed: 2006-10-24
Abstract: Disclosed is the use of caffeine at a concentration of 50 to 500ppm as a plant growth stimulator, to promote maturity in plants, to promote colouration of fruiting in plants and to promote flowering in plants. Also disclosed is an agricultural composition comprising caffeine and a plant nutrient.
Patent NZ-569636-A (NZ)
Title: Improved process for the preparation of the salts of 4-(benzimidazolylmethylamino)-benzamides
Inventor: ZERBAN GEORG
IPC: C07D235/14
Filed: 2006-12-20
Abstract: The disclosure relates to a process for preparing a salt of an optionally substituted 4-benzimidazol-2-ylmethylamino)-benzamidine, wherein: (a) an optionally correspondingly substituted diaminobenzene is condensed with 2-[4-(1,2,4-oxadiazol-5-on-3-yl)-phenylamino]-acetic acid, (b) (i) the product thus obtained is hydrogenated, (ii) optionally the amidino group is carbonylated, without isolating the intermediate product of the hydrogenation beforehand and (iii) without prior isolation of the intermediate product of the carbonylation the desired salt is isolated.
Patent NZ-569676-A (NZ)
Title: Use of DHA, EPA or DHA-derived EPA for treating a pathology associated with cellular oxidative damage
Inventor: DOMINGO PEDROL JOAN CARLES
IPC: A61P27/12
Filed: 2006-12-20
Abstract: Disclosed is the non-therapeutic use of docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), or DHA-derived EPA which is enzymatically incorporated into a glyceride; and wherein said DHA, EPA or DHA derived EPA is in at least 40% by weight in relation to the total fatty acids content of the glyceride; or wherein said DHA, EPA or DHA derived EPA is incorporated into an sn-2 position of the glyceride; as an anti-ageing agent, as a sports performance enhancer in individuals subjected to physical exercise, or for maintaining blood glucose levels in individuals during physical exercise.
Patent NZ-570796-A (NZ)
Title: Mask vent including an annular side wall with vent holes to divide exhaust flow
Inventor: NG EVA
IPC: A61M16/06
Filed: 2008-08-25
Abstract: Disclosed is a vent arrangement (620) for a mask. The arrangement comprises a mask component and a vent cap. The vent cap includes a base wall and a dome or raised portion (638) that extends upwardly from the base wall. The dome or raised portion includes an annular side wall with multiple vent holes (628) arranged radially along the side wall to radially divide exhaust flow over one or more portions totalling at least 90°. The vent holes are open in use at least during the inhalation and exhalation phases of the user's breathing cycle.
Patent NZ-572070-A (NZ)
Title: Inhibitors of c-fms kinase
Inventor: ILLIG CARL R
IPC: A61P35/00
Filed: 2007-04-18
Abstract: Disclosed are phenyl or pyridyl amide compounds of formula (I), or solvates, hydrates, tautomers or pharmaceutically acceptable salts thereof, wherein W is an imidazole, pyrrole or tetrahydrofuran moiety thereof. Also disclosed is the use of the compounds of formula (I) for treating cancer, inflammation, pain, cardiovascular diseases and the like.
Patent NZ-572858-A (NZ)
Title: Preparing material for microbiological fermentations with high pressure steam and jet pump tube in annular ring
Inventor: SKUDDER PAUL JOHN
IPC: C02F3/12
Filed: 2008-11-17
Abstract: The present disclosure relates to a method for preparing organic material for microbiological fermentations of municipal waste water sludge for reducing the waste water sludge and/or of cellulosic material for the production of biofuels, with at least one of the following steps: disintegrating and/or liquefying the organic and/or cellulosic material by using a jet pump and/or creating a supersonic shock zone in a jet pump the organic and/or cellulosic material is supplied to in order to disintegrate and/or liquefy the organic and/or cellulosic material and/or applying high pressure steam to an annular ring chamber enclosing a tube of a jet pump and directing the steam into the tube of the jet pump thereby sucking organic and/or cellulosic material into the tube and creating a supersonic shock zone in the jet pump in order to disintegrate and/or liquefy the organic and/or cellulosic ; material. The present invention also relates to an apparatus for preparing organic material for microbiological fermentations of municipal waste water sludge for reducing the waste water sludge and/or of cellulosic material for production of biofuels comprising a jet pump.
Patent NZ-573621-A (NZ)
Title: Resilient recess former for concrete panel engaging anchor with through hole via separate unitary plug
Inventor: MACKAY SIM ROD
IPC: E02D35/00
Filed: 2007-06-13
Abstract: A recess former (50) is disclosed for use with anchors which are to be cast into a concrete slab. The recess former (50) includes a removable plug (36) and preferably rectangular lugs (57) which engage with corresponding apertures in the attachment head of the lifting anchor and prevent the ingress of cement during casting of the slab. In addition, flaps are preferably provided on the recess former to prevent the sides of the attachment head from being encased in the concrete. Preferably the former is pivoted between open and closed positions and has a slightly V-shaped base which when abutted against a mould or formwork, urges the recess former into the closed position. Furthermore, a recess former is disclosed which stays behind after the casting and remains embedded in the concrete in order to provide a waterproof membrane between the recess and adjacent reinforcing rods (not shown) thereby preventing corrosion of the reinforcing rods. (61) Addition to 579819
Patent NZ-576211-A (NZ)
Title: Workstation screen with transparent and opaque regions
Inventor: BURAK EDWARD JOHN
IPC: A47B96/04
Filed: 2007-10-05
Abstract: A screen e.g. (80) with variable visibility. The screen has various regions (a)-(d). Each region (a)-(d) of the screen provides a different level of possible visibility, which allows for different levels of interactivity between people positioned either side of the screen. Where a high degree of interactivity is required a person can utilise particular regions of the screen, and where low or no degree of interactivity is desired other regions of the screen can be utilised.
Patent NZ-583462-A (NZ)
Title: Acetamide stereoisomer
Inventor: ABOLIN CRAIG R
IPC: C07C233/25
Filed: 2008-08-28
Abstract: Disclosed are isomers of N-[2-hydroxy-5-[1-hydroxy-2-[[2-(4-hydroxyphenyl)-1-methylethyl]amino]ethyl]-phenyl] acetamide. Processes for making the isomers are also disclosed. Also disclosed is the use of the isomers for treating bronchoconstriction associated with reversible obstructive airways disease.
Patent NZ-585525-A (NZ)
Title: Stylet handle attachment device where the engagement portions of the needle hub and stylet handle form a positive lock that restricts the engagement portions from separating in a longitudinal direction
Inventor: DELANO PETER GEORGE
IPC: A61B17/34
Filed: 2008-11-21
Abstract: 585525 A hub assembly 1, comprising a needle hub 4 having a proximal end and a distal end 9 and with a cannula 22 extending through it and protruding from the distal end 9, and a stylet handle 10 having a stylet extending from it with the stylet adapted to be received within a portion of the cannula 22. The needle hub 4 has a first engagement portion 16. The stylet handle 10 has a second engagement portion. Engagement of the first engagement portion 16 of the needle hub 4 and the second engagement portion of the stylet handle 10 form a positive lock, which restricts the first engagement portion 16 from separating from the second engagement portion in the longitudinal direction. The first engagement portion 16 is a recess and the second engagement portion is a protrusion for releasable receipt within the recess. The recess further comprises a shoulder. The protrusion further comprises a restraining end engageable with the shoulder when the needle hub 4 and stylet handle 10 form a positive lock.